Octagon Capital Advisors as of Sept. 30, 2022
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 35 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 29.5 | $171M | 2.5M | 68.30 | |
| Arcus Biosciences Incorporated (RCUS) | 12.0 | $70M | 2.7M | 26.16 | |
| Chinook Therapeutics | 8.7 | $50M | 2.6M | 19.66 | |
| Horizon Therapeutics Pub L SHS | 6.7 | $39M | 625k | 61.89 | |
| Gossamer Bio (GOSS) | 4.2 | $25M | 2.0M | 11.98 | |
| Tandem Diabetes Care Com New (TNDM) | 3.9 | $23M | 475k | 47.85 | |
| Celldex Therapeutics Com New (CLDX) | 3.7 | $21M | 761k | 28.11 | |
| Spdr Ser Tr S&p Biotech (XBI) | 3.3 | $19M | 243k | 79.32 | |
| Mirati Therapeutics | 2.7 | $15M | 221k | 69.84 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.3 | $14M | 1.3M | 10.22 | |
| Vera Therapeutics Cl A (VERA) | 2.0 | $11M | 533k | 21.31 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.9 | $11M | 244k | 44.29 | |
| Intra Cellular Therapies (ITCI) | 1.8 | $10M | 221k | 46.53 | |
| Stoke Therapeutics (STOK) | 1.7 | $9.8M | 764k | 12.84 | |
| Bridgebio Pharma (BBIO) | 1.6 | $9.3M | 934k | 9.94 | |
| Alpine Immune Sciences | 1.5 | $8.8M | 1.2M | 7.20 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.5 | $8.6M | 84k | 103.26 | |
| Karuna Therapeutics Ord | 1.3 | $7.8M | 35k | 224.93 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $7.5M | 37k | 200.16 | |
| Fate Therapeutics (FATE) | 1.3 | $7.4M | 331k | 22.41 | |
| Xilio Therapeutics (XLO) | 1.2 | $7.1M | 2.4M | 2.91 | |
| Avidity Biosciences Ord (RNA) | 1.1 | $6.2M | 380k | 16.33 | |
| 4d Molecular Therapeutics In (FDMT) | 0.7 | $4.0M | 500k | 8.04 | |
| Nuvalent Inc-a (NUVL) | 0.7 | $3.9M | 200k | 19.44 | |
| Jounce Therapeutics | 0.6 | $3.3M | 1.4M | 2.34 | |
| Immunovant (IMVT) | 0.6 | $3.2M | 579k | 5.58 | |
| Dex (DXCM) | 0.6 | $3.2M | 40k | 80.55 | |
| Akero Therapeutics (AKRO) | 0.4 | $2.6M | 75k | 34.05 | |
| Century Therapeutics (IPSC) | 0.4 | $2.2M | 224k | 9.89 | |
| Mirum Pharmaceuticals (MIRM) | 0.4 | $2.1M | 100k | 21.01 | |
| Beigene Sponsored Adr | 0.3 | $1.5M | 11k | 134.78 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $861k | 1.0M | 0.86 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.1 | $581k | 450k | 1.29 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $465k | 20k | 23.25 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.0 | $145k | 30k | 4.83 |
